5
Views
11
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

NF-HB (BSAP) is a Repressor of the Murine Immunoglobulin Heavy-Chain 3'α Enhancer at Early Stages of B-Cell Differentiation

&
Pages 3611-3622 | Received 06 Jan 1993, Accepted 12 Mar 1993, Published online: 01 Apr 2023
 

Abstract

We have identified a nuclear factor expressed in pro-B-, pre-B-, and B-cell lines that binds to two sites within the murine immunoglobulin heavy-chain (IgH) 3'α enhancer (3'αE). These sites were defined by oligonucleotide competition in an electrophoretic mobility shift assay (EMSA) and methylation interference footprinting. The 3'αE-binding factor is indistinguishable from NF-HB (B-lineage-specific nuclear factor that binds to the IgH gene) and the B-lineage-specific transcription factor BSAP by several criteria, including similar cell type distribution of binding activity, cross-competition of binding sites in EMSA, similar protein size as demonstrated by UV cross-linking, and sequence identity of one of the 3'αE-binding sites with a BSAP-binding site within the promoter of the sea urchin late histone gene H2A-2.2. These observations indicate that 3'αE is one of the mammalian targets for NF-HB (BSAP). Transient-transfection assays with chloramphenicol acetyltransferase gene constructs containing 3'αE and mutant 3'αE, in which one of the NF-HB binding sites was inactivated by site-specific mutagenesis, showed ca. five- to sixfold-enhanced activity of mutated 3'αE over parental 3'αE in B-cell lines (NF-HB+), while no significant difference was observed in plasmacytoma cells (NF-HB). We conclude from these observations that NF-HB (BSAP) acts as a repressor of the mouse IgH 3'αE.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.